BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3213029)

  • 1. [Ischemic heart disease--clinical, biochemical and immunobiological parallels].
    Stankusheva G; Chaushev A; Nikolov K; Baleva M; Nachev Ch
    Vutr Boles; 1988; 27(4):88-91. PubMed ID: 3213029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
    Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
    J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reference values of IgA, IgG, IgM, alpha2-macroglobulin, alpha-1- antitrypsin, complement C3, complement C4, ceruloplasmin, haptoglobin, properdin factor B, acid alpha-1 glycoprotein and transferrin concentration in the blood of healthy children].
    Liappis N; Rossmöller M; Dörner K; Hildenbrand G
    Klin Padiatr; 1983 Mar; 195(2):107-16. PubMed ID: 6190038
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
    Dacheva V; Dimov DM; Nedialkova V; Koleva P
    Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunochemical study of the alpha 2-glycoprotein from the atherosclerotically altered aortic wall in the blood serum of ischemic heart disease patients].
    Murashko VV; Baranov AP; Kamenets AV; Tatarinov IuS; Chekhonin VP
    Ter Arkh; 1985; 57(9):37-9. PubMed ID: 2417347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
    Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
    Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement system proteins in the acute phase of myocardial infarction].
    Gukasian IA; Kovanov VV; Khil'kin AM; Shmelev IA
    Vopr Med Khim; 1980; 26(3):362-5. PubMed ID: 7456367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-laboratory parallels in the diagnosis of coronary insufficiency].
    Kogut MD
    Vrach Delo; 1972 Oct; 10():34-8. PubMed ID: 4658401
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement and sepsis.
    Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
    Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glycoprotein changes in acute myocardial infarction (author's transl)].
    Iacobone G; Agostinelli M; Cerioni M; Conti V; Ganzetti S; Iannopollo M; Melappioni A; Ciardi E
    G Ital Cardiol; 1977; 7(12):1156-61. PubMed ID: 598634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
    Ikonnikova EI; Katkova NB; Filippova SB
    Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response in acute coronary syndromes.
    Jan V; Jalal S; Aslam K; Iqbal K; Tramboo N; Alai MS; Rather H; Lone N
    Indian Heart J; 1999; 51(5):515-20. PubMed ID: 10721642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermediate forms of ischemic heart disease. Unstable angina (stenocardia)].
    Belov Iu; Tsenov I; Kusitasev G
    Vutr Boles; 1978; 17(6):1-7. PubMed ID: 366902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological changes in the exacerbated form of chronic obstructive pulmonary disease].
    Marinov Kh; Balanova A; Nikolov K; Baleva M; Terzieva Ts
    Vutr Boles; 1986; 25(2):60-3. PubMed ID: 2424179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris.
    Giasuddin AS; ElMahdawi JM; ElHassadi FM
    Bangladesh Med Res Counc Bull; 2007 Dec; 33(3):98-102. PubMed ID: 18783065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulins, C3 and C4 levels in patients with burns.
    Menon T; Sundaram BM; Subramanian S; Sundararajan CR
    Indian J Pathol Microbiol; 1984 Jul; 27(3):209-14. PubMed ID: 6442279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic changes in blood cells in various forms of ischemic heart disease].
    Shepotinovskiĭ VI; Mikashinovich ZI
    Vopr Med Khim; 1984; 30(1):25-8. PubMed ID: 6710933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.